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Background: Adipocytes, which are the main cellular component of adipose tissue, are the building
blocks of obesity. The nuclear hormone receptor PPARg is a major regulator of adipocyte differentiation
and development. Obesity, which is one of the most dangerous yet silent diseases of all time, is fast
becoming a critical area of research focus.
Methods: In this study, we initially aimed to investigate whether the ginsenoside Rf, a compound that is
only present in Panax ginseng Meyer, interacts with PPARg by molecular docking simulations. After we
performed the docking simulation the result has been analyzed with several different software programs,
including Discovery Studio, Pymol, Chimera, Ligplus, and Pose View. All of the programs identiﬁed the
same mechanism of interaction between PPARg and Rf, at the same active site. To determine the drug-
like and biological activities of Rf, we calculate its absorption, distribution, metabolism, excretion, and
toxic (ADMET) and prediction of activity spectra for substances (PASS) properties. Considering the results
obtained from the computational investigations, the focus was on the in vitro experiments.
Results: Because the docking simulations predicted the formation of structural bonds between Rf and
PPARg, we also investigated whether any evidence for these bonds could be observed at the cellular level.
These experiments revealed that Rf treatment of 3T3-L1 adipocytes downregulated the expression levels
of PPARg and perilipin, and also decreased the amount of lipid accumulated at different doses.
Conclusion: The ginsenoside Rf appears to be promising compound that could prove useful in antiobesity
treatments.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction concluded that obesity added for 0.7e2.8% of the total healthcareThe global prevalence of obesity has been increasing at a
dreadful rate, with both developed and developing countries
affected by this disease. In 2005, the World Health Organization
predicted that at least 400 million adults worldwide were obese;
moreover, this number is estimated to double in approximately
10 yr. In Western countries, which generally are also high-income
countries, obesity has typically been associated with a high-calorie
diet and a low level of physical activity; however, low- and middle-
income countries are increasingly dealing with these burdens as
well [1]. In combination with heavy smoking or drinking, obesity
has been found to be associated with several chronic medical
conditions and a limited quality of life [2]. In a systematic review of
the economic burden of obesity worldwide, Withrow et al [3]cheon-dong, Giheung-gu, Yongin-s
erms of the Creative Commons At
ribution, and reproduction in any
e Korean Society of Ginseng, Publexpenses of a given country; moreover, obese people incurred 30%
higher medical costs compared with people of normal weight.
Obesity is a complex metabolic disorder, and is related to a higher
risk of many important human diseases, including type 2 diabetes,
hypertension, cardiovascular disease, stroke, and certain types of
cancer such as colorectal, breast, and prostate [4]. Therefore, the
development of effective antiobesity drugs is crucial for treating
obesity and reducing the risk of its associated disorders. For years,
researchers have been searching for drugs or naturally derived
compounds that can effectively treat obesity. However, satisfactory
results have yet to be achieved; thus, intense research is still
focused on the identiﬁcation of antiobesity agents. Panax ginseng of
the Araliaceae family is one of the most beneﬁcial of Asian plants.
Since ancient times, ginseng has been used as a curative drug and asi, Gyeonggi-do 449-701, Korea.
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as China, Japan, and Korea. Currently, ginseng has also been used in
a variety of commercial health products worldwide, including
ginseng capsules, soups, drinks, and cosmetics. Chemical studies of
ginseng have revealed that it contains saponins, antioxidants,
peptides, polysaccharides, fatty acids, alcohols, and vitamins. Sa-
ponins, which are also known as ginsenosides, are broadly believed
to be the most highly bioactive compounds in ginseng [5]. Based on
their chemical structure, ginsenosides are generally divided into
two groups: protopanaxadiol (PD) and protopanaxatriol (PT). The
PD includes ginsenosides such as Rb1, Rb2, Rc, Rd, Rg3, Rh2, and
Rh3; for these ginsenosides, the group the sugar moieties are
attached to the 3-position of the dammarane-type triterpine.
However, the sugar moieties of PT are attached to the 6-position of
the dammarane-type triterpine; these ginsenosides include com-
pounds such as Re, Rf, Rg1, Rg2, and Rh1 [6]. Ginsenosides, either as
crude or single saponins, were thought for years to be responsible
for most pharmacological actions of ginsengs [7]. The ginsenoside
Rf, which is a ginseng saponin found only in P. ginseng [8], is a
steroid-like compound harboring several sugar moieties that has
also been shown to exert protective effects against several diseases
[9,10]. Therefore, in this study we investigated whether this gin-
senoside interacts with peroxisome proliferator activated receptors
gamma (PPARg) which is the major transcriptional factor of
adipocyte and is mainly present in adipose tissue. The biology of
PPARs indicates for the regulation of lipid metabolism and function
[11]. Molecular docking simulation was performed and then vali-
dated this result with ﬁve different software programs; each pro-
gram predicted the same mechanism of bond formation at the
same active site residues of protein with compound Rf. Next, we
characterized Rf pharmacologically by determining its absorption,
distribution, metabolism, excretion and toxic (ADMET) properties
and its prediction of activity spectra for substances (PASS). To
validate these observations experimentally and to observe the
outcome of Rf binding to PPARg, we carried out in vitro experiments
in which 3T3-L1 adipocytes were treated with Rf. These experi-
ments revealed that Rf was effective in reducing lipid accumulation.
Moreover, reverse transcription polymerase chain reaction (RT-
PCR) and quantitative real-time polymerase chain reaction (qRT-
PCR) analyses also revealed that Rf treatment of 3T3-L1 adipocytes
downregulated the expression of PPARg and perilipin. The in silico,
ADMET, PASS, and experimental results presented here indicated
that Rf may be an applicatory compound to ameliorate obesity.
2. Methods
2.1. Docking and screening
Molecular docking is a commonly and frequently applied tech-
nique in drug design, due to the ability of this technique to predict
the speciﬁc positioning of a ligand in the active site of a protein [12].
For any sort of biological process, interactions between bio-
molecules are elemental are fundamental. Therefore we performed
molecular docking to simulate the interaction of Rf from P. ginseng
with PPARg. Therefore, the molecular docking program Autodock
4.2.3 (La Jolla, USA) was used [13e15]. The structure of Rf was ob-
tained from our in-house database of P. ginseng saponins structures.
The crystal structure of PPARg, at 2.28 A resolution was obtained
from the Protein Data Bank (PDB) (PDB ID: 2ATH) [16,17]; this
structure is a co-crystallization of PPARg in complex with one of its
ligands, 3EA. To obtain the structure of PPARg alone the co-crys-
tallized ligand was removed from the PDB structure; to conﬁrm the
reproducibility of the binding of PPARg to 3EA, the ligand was
redocked into PPARg. The residues found to interact with 3EA, a
known inhibitor of PPARg, were considered crucial residues in theactive site of PPARg. Previous studies have demonstrated that res-
idues TYR473, HIS449, SER289, and HIS323 are crucial for the in-
hibition of PPARg [16]. Water molecules were removed from the
PPARg structure, and hydrogen atoms were added. To more pre-
cisely identify the binding mode between PPARg and Rf the La-
marckian genetic algorithm (LGA) was also performed [18e20]. In
the molecular docking simulation between PPARg and Rf, the
essential amino acids were selected. The molecular optimization
and docking simulation parameters used have been previously
described [21]. To validate the docking interaction the simulation
output was analyzed with Discovery Studio (DS) 3.5, Chimera,
Pymol, Pose View, and Ligplus.2.2. Prediction of ADMET and PASS prediction
Pharmacokinetic studies of a potential drug generally involve
determining its ADMET properties. This determination is particu-
larly important because it has been estimated that more than 50%
of all potential drugs fail during clinical trials due to their inade-
quate ADMET properties [22]. Improvements in computational
studies and in the drug discovery process have enabled the iden-
tiﬁcation of several pharmacologically active compounds, which
must be optimized and also undergo preclinical ADMET evalua-
tions. It is extremely important to determine the ADMET properties
of a compound before clinical trials; thus, we determined the
ADMET properties for Rf using methods previously described
[23,24]. In addition, we also used another computational program,
PASS, to predict the possible biological activities of Rf based on its
chemical structure [25,26]. In particular, we determined the
possible biological activity scores related to obesity for Rf [27]. This
approach yielded a list of potential biological activities mediated by
Rf, along with their associated probabilities of activity (Pa) and
probabilities of inactivity (Pi).3. Experimental study
3.1. Materials
The ginsenoside Rf was obtained from the Kyung Hee University
Ginseng Research Bank (Yongin, South Korea) in powdered form,
and was determined to be 95% pure by high-performance lipid
chromatography. Insulin and isobutylmethylxanthine (IBMX) were
obtained from Wako (Tokyo, Japan); dexamethasone was pur-
chased from Sigma Chemical Company (St. Louis, MO, USA). Dul-
becco’s modiﬁed Eagle’s medium (DMEM) was obtained from
Welgene (Daegu, Korea). Newborn calf serum was purchased from
Gibco (NY, USA), and antibiotic solution was purchased from Bio-
logical Industries (Kibbutz Beit Haemek, Israel).3.2. Cell culture and differentiation
3T3-L1 preadipocytes were obtained from the American Type
Culture Collection (ATCC;Manassas, VA, USA). Cellswere cultured in
DMEM, supplemented with 10% Bovine Calf Serum (BCS) and 1%
Antibiotic (AB), at 37C in a 5% CO2 atmosphere. Differentiationwas
induced 3 days after conﬂuence was reached (deﬁned as Day 0) by
culturing cells in differentiation medium (DM) from day 0 to day 3.
The DM contained DMEM, 10% BCS, 1% AB, and DMI (1mM dexa-
methasone, 0.5mM IBMX, and 10 mg/mL insulin). Cells were addi-
tionally fed with growth medium containing DMEM, 10% BCS, and
10 mg/mL insulin on Days 3, 5, and 7. In all experiments, themedium
also contained Rf at a concentration of either 10mM or 100mM from
Day 0 until the day of the experiment.
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Cellswereplated in96-well plates at a density of 1104 cells/well.
After 24 h, themediumwas replacedwithDMEMcontaining 10%BCS
and Rf at a concentration of 1 mM,10 mM, 50 mM, or100 mM; cells were
then incubated for 48 h. After this incubation, 20 mL of MTT reagent
was added to the medium, and cells were incubated for 4 h at 37C.
Themediumwas then replacedwith 100 mLDMSO, and the cellswere
incubated for another hour. Finally, the resultant ODs at 570 nmwere
measured with an enzyme-linked immunosorbent assay reader3.4. Oil Red O staining
Cells were differentiated in 24-well plates; on day 8, Oil Red O
staining was performed. Cells were ﬁxed with 10% formalin for 1 h,
washed with 60% isopropanol, and then stained with Oil Red O
solution for 1 h. Excess stainwas removed bywashing the cells with
sterile water, and cells were then dried for imaging. Finally, lipid
droplets were solubilized in 100% isopropanol and quantiﬁed by
determining the resultant absorbances at 520 nm.3.5. RNA preparation and RT-PCR
Cells were differentiated either in the presence or absence of Rf;
on Day 8, total RNA was extracted using a total RNA extraction kit
(Intron Biotechnology, Seongnam-si, Korea). Complementary DNA
(cDNA) was then synthesized from 1 mg of total RNA with a cDNA
synthesis kit (Thermo Scientiﬁc, Waltham, MA, USA). PCR ampliﬁ-
cation was then performed using the following gene-speciﬁc
primers: PPARg; forward, 50-ATGGGTGAAACTCTGGGAGATT-30;
reverse, 50-AGCTTCAATC GGATGGTTCTT-30; perilipin; forward, 50-
GATCGCCTCTGAACTGAAGG-30; reverse, 50-CTTCTCGATGCTTCCCA-
GAG-30; beta-actin; forward, 50-ATGAAGTGTGACGTTGACATCC-30;
reverse, 50-CCTAGAAGCATTTGCGGTGCACGATG-30. Thermocycling
conditions were as follows: denaturation at 94C for 30 s, annealing
at 58C (PPARg) or 60C (perilipin and beta-actin), and extension at
72C for 1 min; 28 of these cycles were carried out. The resultant
PCR products were electrophoresed on a 1% agarose gel and visu-
alized with Image J software.3.6. Quantitative real-time polymerase chain reaction
qRT-PCR was performed using real-time rotary analyzer (Rotor-
Gene 6000; Corbet Life Science, Sydney, Australia) and 1 mg of cDNA
in a 10-mL reaction volume. SYBR Green SensiMix Plus Master Mix
(Quantace, London, England), was used with the following gene
speciﬁc primers: PPARg; forward, 50-ATGGGTGAAACTCTGGGA-
GATT-30; reverse, 50-AGCTTCAATCGGATGGTTCTT-30; perilipin; for-
ward, 50-GATCGCCTCTGAACTGAAGG-30; reverse, 50-CTTCTCGAT
GCTTCCCAGAG-30; beta-actin; forward, 50-ATGAAGTGTGACGTT-
GACATCC-30; reverse, 50-CCTAGAAGCATTTGCGGTGCACGATG-30.
Thermocycling parameters were 95C for 10 s, 60C for 10 s, and
72C for 20 s. Beta-actin was used as an internal control gene.3.7. Statistical analysis
All experiments were performed independently three times:
data are presented as means  standard error (SE). Mean values
were compared between the treated groups and the untreated
groups using Graph Pad (La Jolla, CA 92037, USA) t test quick calc
version 6.04. Statistical signiﬁcance is designated by the following
symbols: *p < 0.05; **p < 0.005; and ***p < 0.0005.4. Results
4.1. Molecular interaction study
A molecular docking simulation of the interaction between Rf
and PPARgwas carried out with Autodock; this interactionwas also
then analyzed with DS 3.5, Pymol, Chimera, Ligplus, and Pose View.
The accuracy of the AutoDock result was conﬁrmed by the obser-
vation that it yielded the lowest binding free energy out of all
possible docking positions, in addition to assigning hydrogen bonds
between PPARg and Rf. The docking simulation between Rf and
PPARg predicted the formation of two hydrogen bonds at residues
Ser289 and His323 in the active site of PPARg; this simulation also
predicted a binding afﬁnity of 2.9 kcal/mol. Both His323 and
Ser289 are considered to be important residues for ligand inter-
action in the active site of PPARg [28,29]. The high level of agree-
ment between the results from the ﬁve different programs supports
the mechanism of interaction between Rf and PPARg, in addition to
the speciﬁc bonds formed between Rf and PPARg. The predicted
docking interactions of Rf with PPARg, including the hydrogen
bonds of these interactions, are shown in Fig. 1.
The structure obtained with DS 3.5 predicted that the hydrogen
atoms of PPARg Ser289 and His323 form a bond with the oxygen
atom of Rf. Additionally, two hydrogen bonds are formed between
PPARg Phe282 and Met364 and Rf.
Similarly, the interaction simulated by Pose View predicted the
formation of a bond between the hydrogen atoms in the Ser289 and
His323 residues of PPARg and the oxygen atom of Rf. In addition,
Pose View predicted the formation of hydrogen bonds between
PPARg Met348 and Met364 and Rf.
The Ligplus simulation also predicted hydrogen bond in-
teractions between the Ser289 and His323 residues of PPARg and
the oxygen atom in Rf.
In agreement with the other simulations, Pymol also predicted
hydrogen bonds between the PPARg active site residues Ser289 and
His323 and Rf, in addition to hydrogen bond formation between
PPARg Phe282 and Met364 and Rf.
The Chimera program also yielded the same hydrogen bond
formations, between PPARg Ser289 and His323 and the oxygen
atom of Rf. In addition, Chimera predicted additional hydrogen
bonds between PPARg Phe282 and Met364 and Rf.
From the results of docking simulation, it was found that the
individual program shows the same mechanism of hydrogen bond
formation of ginsenoside Rf at the same active site residue of
PPARg, which are Ser289 and His323.
The control compound 3EA showed interactions at four active
site residues: Ser 289, His 323, His 449, and Tyr 473 [16]. These
interactions resulted in a binding afﬁnity of 10.0 kcal/mol. Based
on these results, Rf was also predicted to exhibit a good binding
afﬁnity with PPARg.
4.2. ADMET and PASS analysis
Using the Qikprop module in the Schrödinger program, the
physiochemical and pharmaceutically properties of Rf were
determined. These properties included molecular weight, human
oral absorption in the gastrointestinal tract, serum protein bind-
ing, CYP2D6 inhibition probability, and octanol/water partition
coefﬁcient. Because toxicity prediction is also very important in
natural product research [30], we also predicted the hepatotox-
icity descriptors for Rf using the ADMET module in DS 3.5. The
detailed results of the predicted ADMET values for Rf, along with
their acceptable ranges, are listed in Table 1. Next, the computa-
tional program PASS was used to predict the biological activity
spectrum of Rf. This analysis suggested that Rf could exhibit
Fig. 1. Hydrogen bond formation between Rf and residues in the active site of PPARg as visualized by (A) Lig Plus, (B) Pose View, (C) DS 3.5, (D) Chimera, and (E) Pymol.
J Ginseng Res 2015;39:141e147144activity (Pa > 0.7) as a transcription factor inhibitor, an antidia-
betic agent, a cholesterol antagonist, a cholesterol synthesis in-
hibitor, an antihypercholesterolemic agent, a cholesterol
absorption inhibitor, and a lipid metabolism regulator. All of these
functions are directly or indirectly related to fat, as well as to
obesity (Table 2).
4.3. Experimental study
To investigate whether Rf exhibited any cytotoxicity, cell via-
bilities were determined after 48 h in the presence of various
concentrations of Rf, including 1, 10, 50, and 100mM. Rf was not
found to be signiﬁcantly cytotoxic to 3T3-L1 cells, even at the
highest concentration tested (100mM; Fig. 2).Table 1
ADMET results of selected ginsenoside Rf with pharmacokinetic properties
Ginsenoside MW Solubility level QP (%)a QplogKhsaa
Rf 640.8 5.3 49.4 0.2
Aqueous solubility (Solubility level) (accepted range ¼ 6.5e0.5)
CYP2D6 inhibition ¼ 0 is Non-inhibitor and 1 is inhibitor
Hepatotoxicity ¼ 0 is non-toxic and 1 is toxic
Lipinski rule of 5 violations ¼ Maximum is 4 violations
MW ¼ Molecular weight accepted range 130e725
QP (%) ¼ Percentage of human oral absorption in GI (acceptable range ¼ <25% is poor a
QPlogKhsa ¼ Serum protein binding (acceptable range ¼ 1.5/1.5)
QPlogPo/w ¼ Octanol/water partition coefﬁcient (acceptable range ¼ 0.2 to 6.5)
a Predicted values using Qikprop program in Schrödinger
b Predicted values using ADMET descriptors in Discovery Studio 3.54.4. Oil Red O staining and lipid accumulation
Oil Red O staining was performed to examine the extent of lipid
accumulation in 3T3-L1 adipocytes undergoing adipogenesis,
either in the presence or absence of Rf. Visualization of Oil Red O-
stained cells clearly revealed the accumulation of lipids in DMI-
treated cells, whereas cells treated with Differentiation Media In-
dex (DMI) in the presence of Rf accumulated lipids to a lesser extent
(Fig. 3A). To quantify the triglyceride contents of the cells, the
absorbance of the solubilized Oil Red O was measured for each
treatment. Cells differentiated in the presence of Rf (10 and 100mM)
contained 14% and 45% less lipid, respectively, compared with
positive control differentiated cells (Fig. 3B). This result suggests
that Rf treatment inhibits adipocyte differentiation.CYP2D6 inhibitionb Hepatotoxicityb QPlogPo/wa Lipinski rule
of 5 violations
0.3 0 2.9 2
nd >80% is high)
Fig. 2. Cytotoxicities of different concentrations of Rf on 3T3-L1 adipocytes. The MTT
assay was performed on cells after 48 h of incubation with Rf.
Table 2
Predicted biological activity (Pa) and inactivity (Pi) of ginsenoside Rf
Pa Pi Activity
0.907 0.003 Cholesterol antagonist
0.605 0.005 Transcription factor inhibitor
0.565 0.015 Antidiabetic
0.480 0.004 Cholesterol synthesis inhibitor
0 391 0.039 Antihypercholesterolemic
0.239 0.177 Lipid metabolism regulator
0.049 0.011 Cholesterol absorption inhibitor
F.M. Siraj et al / In silico and in vitro analysis of Rf 1454.5. Gene expression levels of PPARg and perilipin
Finally, the gene expression levels of PPARg and perilipin were
determined. PPARg is the main transcription factor driving adipo-
genesis [11], whereas perilipin is a lipid droplet-associated protein
[31]. The upregulation of these genes generally signiﬁes increased
triacylglycerol metabolism. Perilipin is found on the surface of
every differentiated adipocyte and also envelopes the coreFig. 3. Effects of Rf (10 and 100 mM) on 3T3-L1 adipocyte differentiation. Lipid contents w
absorbance measurements (B). *p < 0.0005 between the negative control and positive contriacylglycerols in intracellular lipid droplets; these observations
hold true in both transformed adipocytes and also in primary adi-
pocytes derived from white and brown adipose tissue [32].These
two markers have been determined to play distinct, yet necessary,
roles in adipogenesis; thus, the messenger RNA (mRNA) expression
levels of these two genes were quantiﬁed. To this end, 3T3-L1 cells
were differentiated, treated with Rf, and the expression proﬁles of
PPARg and perilipinwere investigated by RT-PCR and qRT-PCR. This
analysis revealed that the expression levels of PPARg and perilipin
were increased in DMI-treated adipocytes compared with control
cells, which did not receive either DMI or Rf. However, the
expression levels of PPARg and perilipinwere downregulatedwhen
cells were treated with Rf in the presence of DMI (Fig. 4A). Inter-
estingly, treatment with Rf at concentrations of 10 and 100 mM
reduced the mRNA levels of PPARg by 8% and 52%, and the mRNA
levels of perilipin by 14% and 65%, respectively (Fig. 4B). These re-
sults support the hypothesis that treatment with Rf inhibits adi-
pogenesis, and indicate that the mechanism may involve the
downregulation of key mediators of adipogenesis.
5. Discussion
The prevalence of obesity has increased dramatically world-
wide, and it is now considered to be one of the leading global health
risks. Moreover, obesity also causes several other health problems
such as diabetes, heart disease, and some forms of cancer. Medic-
inal compounds derived from plants can interact extremely efﬁ-
ciently with biological systems, because they are obtained directly
from nature. Thus, plants are considered to be important sources
for the identiﬁcation of novel drug candidates. Until now several
studies have been reported showing that P. ginseng has always been
an important plant showing efﬁcacy on obesity [33]. Our recent
works have reported that ginsenoside F2 and Rh1 had structural
interactionwith PPARg andwhen it was checked at the in vitro level
on adipocyte cell line, they possessed efﬁcacy in blocking the
process of adipogenesis that may lead to work as an anti- obesity
component [27,34]. In this study, we used an automated dockingere visualized by Oil Red O staining on Day 8 of differentiation (A) and quantiﬁed via
trol groups. **p < 0.005; ***p < 0.0005 between the positive and treated groups.
Fig. 4. Transcriptional effects of Rf on adipocytes. Total RNA was isolated on Day 8 of
differentiation. Control cells were treated with normal medium, whereas positive
control cells received differentiation medium (DMI). Treated groups received differ-
entiation medium with different concentrations of Rf (DMIþRf). The expression levels
of various genes were evaluated by real-time polymerase chain reaction. (A) Ampli-
ﬁcation products were visualized by gel electrophoresis. (B) Quantiﬁcation of
messenger RNA expression levels by quantitative real-time polymerase chain reaction.
###p < 0.0005 between the control group and the positive control group. *p < 0.05;
**p < 0.005; and ***p < 0.0005 between the DMI-treated positive control group and
the DMIþRf group.
J Ginseng Res 2015;39:141e147146program to generate a model of Rf docked with PPARg, and
observed that Rf was indeed docked closely in the active site of
PPARg in this model. The results of this docking simulation were
conﬁrmed by several different docking programs; based on this
agreement, we determined the ADMET properties of Rf. The
ADMET values indicate that Rf has the potential to be a suitable
drug. Moreover, the PASS results also suggest that Rf can perform
useful biological activities. Because our computational studies
indicated that Rf could be useful as a biologically active, drug-like
compound, we next endeavored to test the effects of Rf in in vitro
assays using 3T3-L1 adipocytes. We ﬁrst conﬁrmed that Rf was not
cytotoxic at the concentrations used in our assays. Lipid accumu-
lation assays of treated adipocytes revealed that Rf-treated adipo-
cytes exhibited lower levels of intracellular lipids compared with
untreated adipocytes, as assessed by both visualization and quan-
tiﬁcation of absorbances. Moreover, we found that Rf treatment ofadipocytes downregulated the mRNA levels of PPARg and perilipin,
as assessed by both RT-PCR and qRT-PCR. Cumulatively, the
computational and experimental data presented here suggest that
Rf, a ginsenoside obtained from the medicinal plant P. ginseng, may
help attenuate obesity by interacting with PPARg and inhibiting
adipogenesis. However, further studies in animal models will be
required to assess the true potential of Rf as an antiobesity drug.
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